Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines.
about
Protective efficacy of centralized and polyvalent envelope immunogens in an attenuated equine lentivirus vaccineB Cells and Functional Antibody Responses to Combat InfluenzaChallenges and future in vaccines, drug development, and immunomodulatory therapyCocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades.Emerging influenza viruses and the prospect of a universal influenza virus vaccine.Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity.Strategies towards universal pandemic influenza vaccines.Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses.Progress in developing virus-like particle influenza vaccines.Characterization of immune responses induced by immunization with the HA DNA vaccines of two antigenically distinctive H5N1 HPAIV isolatesPATH Influenza Vaccine Project: accelerating the development of new influenza vaccines for low-resource countries.The prospects and challenges of universal vaccines for influenzaResidual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity.Influenza vaccines: challenges and solutions.Protein engineering strategies for the development of viral vaccines and immunotherapeutics.Bioengineering virus-like particles as vaccines.Strategies to induce broadly protective antibody responses to viral glycoproteins.Roads to advanced vaccines: influenza case study.Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.Vaccine approaches conferring cross-protection against influenza viruses.Universal influenza vaccine: the holy grail?The Hard Way towards an Antibody-Based HIV-1 Env Vaccine: Lessons from Other Viruses.Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses
P2860
Q21131325-8A7753AC-7721-4B11-B047-B0D4AA14D379Q26801639-E90238F8-BA07-46E9-BE85-757C9967A96EQ26853354-04397C3D-5FF0-4C63-8D4B-13921356BC9AQ30371649-7EEC26BE-F417-4A2A-AC61-389918D07BD1Q30372274-67A3B460-7A50-45FC-9A92-A2FE00480FF2Q30376724-0BE092A6-EC32-4995-81DD-D3D524D2F99DQ30382226-60C04494-F184-4552-95EE-8B08936E8673Q30384878-348B9938-5264-4317-866F-2047AF89B4BCQ30386640-5392917C-68B5-48C9-9A3D-B54014770C1DQ30420017-D4DF2B67-F082-40C4-AE4C-C1EB3635FE7EQ30421549-40A77967-F967-47E9-AFF6-251EA626678DQ30430703-2B7E56A4-9722-4AF7-8DA8-F8066B3B47CEQ34511080-0DC3256D-6F95-47D1-8A2B-7C8201C376E6Q35184572-50C6093A-B207-4CE5-9821-F5853A8E13DFQ37625877-63F2F5C4-4E41-4385-AD99-61DC83A9F0B7Q38172045-BBC7873F-92C7-426C-BAA0-268FA8CAA74DQ39170802-E333EBB3-5608-40C4-BD63-5832A329789DQ40092863-64AAFEF6-BD22-4B2E-8AA7-AF5A1668E6A6Q41924161-06CF1924-9095-430C-B757-6BBBC5741186Q41934895-F3FD7D04-F6C8-4629-A946-E03D9F17BAA7Q43692141-09E413F8-BBF3-429B-B1DC-1A41BCB983A1Q52584646-645FF835-CCA8-41C2-8028-BA094F550B58Q59126472-5E001C81-AE36-4BE1-A781-4EEE51B9D772
P2860
Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Antibody breadth and protectiv ...... virus-like particle vaccines.
@ast
Antibody breadth and protectiv ...... virus-like particle vaccines.
@en
type
label
Antibody breadth and protectiv ...... virus-like particle vaccines.
@ast
Antibody breadth and protectiv ...... virus-like particle vaccines.
@en
prefLabel
Antibody breadth and protectiv ...... virus-like particle vaccines.
@ast
Antibody breadth and protectiv ...... virus-like particle vaccines.
@en
P2093
P2860
P356
P1476
Antibody breadth and protectiv ...... virus-like particle vaccines.
@en
P2093
Brendan M Giles
Clayton A Wiley
Dilhari R Dealmeida
Stephanie J Bissel
Ted M Ross
P2860
P304
P356
10.1128/CVI.05533-11
P577
2011-12-21T00:00:00Z